What actually changed in 2025 — and what will matter in 2026
This pre-conference eBook distills market intelligence and regulatory signals to help senior clinical operations leaders cut through the noise before SCOPE.
It covers why AI consolidation accelerated, how oversight is evolving in distributed trials, where build-vs-buy decisions have shifted across AI, DCT, TMF, and FSP, and the strategic bets already separating top sponsors. This is not a trend report, but a strategic briefing to guide conversations and decisions at SCOPE.
Which themes are dominating real sponsor conversations, which vendors are drawing serious attention, and which narratives are already losing credibility with direct implications for 2026 planning.
Where AI is truly delivering ROI versus where scale breaks down including recruitment, feasibility, protocol optimization, RBQM, and validation burden.
How sponsors are moving away from traditional staff augmentation toward embedded expertise, lower attrition models, and faster speed-to-productivity and what that means for CRO dependence.
The strategic implications sponsors are acting on immediately, including which capabilities to own, which to rent, and where regulatory scrutiny is intensifying.
A comprehensive post-conference report distilling:
The three strategic decisions that will define sponsor competitiveness in 2026
What sponsors are doing differently across AI, oversight, TMF, and FSP models
Which vendor claims held up under scrutiny and which did not
How to translate SCOPE insights into concrete post-conference decisions
Built to support executive readouts, board discussions, and 2026 planning cycles.
Erik Horner is a life sciences professional with rich experience supporting biopharma organizations through his work at Clinovo and, previously, at Advanced Clinical, collaborating with life science organizations to advance clinical programs and operational initiatives.
As Vice President at Clinovo, Matt Gallant brings deep experience in the clinical research sector and workforce strategy, with prior experience at Advanced Clinical, and regularly shares insights on improving efficiency and outcomes across the biopharma ecosystem.
At Clinovo, we deliver expert-led technology and workforce optimization solutions that accelerate clinical development with targeted precision. Eliminate barriers, achieve measurable ROI, and bring life-changing therapies to market faster.
Quick Links
Contact Us
Visit Us
Copyright 2025 Clinovo | All Rights Reserved
